Foster, NL, Chase, TN, Mansi, L, Brooks, R, Fedio, P.
Cortical abnormalities in Alzheimer’s disease. Ann Neurol
1984; 16: 649–654.
Friedland, RP, Budinger, TF, Ganz, E
et al. Regional cerebral metabolic alternations in dementia of the Alzheimer type: positron emission tomography with (18F)fluorodeoxyglucose. J Comput Assist Tomogr
1983; 7(4): 590–598.
Cutler, NR, Haxby, JV, Duara, R
et al. Clinical history, brain metabolism, and neuropsychological function in Alzheimer’s disease. Ann Neurol
1985; 18: 298–309.
McGeer, PL, Kamo, H, Harrop, R, et al. Positron emission tomography in patients with clinically diagnosed Alzheimer’s disease. Can Med Assoc J
1986; 134: 597–607.
Neary, D, Snowden, JS, Shields, RA, Burjan, AWI, Northen, B
Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry
1987; 50: 1101–1109.
Gemmell, HG, Sharp, PF, Besson, JAO
et al. Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study. J Comput Assist Tomogr
1987; 11(3): 398–402.
Perani, D, Di Piero, V, Vallar, G, Cappa, S, Messa, C.
Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer’s disease. J Nucl Med
1988; 29: 1507–1514.
Jagust, WJ, Budinger, TF, Reed, BR
The diagnosis of dementia with single photon emission computed tomography. Arch Neurol
1987; 44: 258–262.
Pearlson, GD, Harris, GJ, Powers, RE
et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer’s disease. Arch Gen Psychiatry
1992; 49(5): 402–408.
Bonte, FJ, Ross, ED, Chehabi, HH, Devous, MD
SPECT study of regional cerebral blood flow in Alzheimer disease. J Comput Assist Tomogr
1986; 10(4): 579–583.
Johnson, KA, Mueller, ST, Walshe, TM, English, RJ, Holman, BL
Cerebral perfusion imaging in Alzheimer’s disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. Arch Neurol
1987; 44: 165–168.
Pizzolato, G, Dam, M, Borsato, N, et al. [99mTc]-HM-PAO SPECT in Parkinson’s disease. J Cereb Blood Flow Metab
1988; 8: S101–S108.
Spampinato, U, Habert, MO, Mas, JL
et al. (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson’s disease: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry
1991; 54: 787–792.
Launes, J, Sulkava, R, Erkinjuntti, T
et al. 99TcM-HMPAO SPECT in suspected dementia. Nucl Med Commun
1991; 12: 757–765.
Duara, R, Grady, C, Haxby, J
et al. Positron emission tomography in Alzheimer’s disease. Neurology
1986; 36: 879–887.
Haxby, JV, Grady, CL, Duara, R, Cutler, NR, Rapoport, SI. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer’s disease. J Cereb Blood Flow Metab
1985; 5(2): 193–200.
Haxby, JV, Grady, CL, Duara, R
et al. Neocortical metabolic abnormalities precede non-memory cognitive defects in early Alzheimer’s type dementia. Arch Neurol
1986; 43: 882–885.
O’Brien, JT, Eagger, S, Syed, GMS, Sahakian, BJ, Levy, R
A study of regional cerebral blood flow and cognitive performance in Alzheimer’s disease. J Neurol Neurosurg Psychiatry
1992; 55: 1182–1187.
Karbe, H, Kertesz, A, Davis, J
et al. Quantification of functional deficit in Alzheimer’s disease using a computer–assisted mapping program for 99mTc-HMPAO SPECT. Neuroradiology
1994; 36: 1–6.
Jobst, KA, Smith, AD, Barker, CS
et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer’s disease. J Neurol Neurosurg Psychiatry
1992; 55(3): 190–194.
Liu, HC, Liu, RS, Lin, KN
et al. Single photon emission computed tomography using 99Tcm-HMPAO in Alzheimer’s disease. Nucl Med Commun
1992; 13: 535–541.
Claus, JJ, van Harskamp, F, Breteler, MMB
et al. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer’s disease: a population-based study. Neurology
1994; 44: 454–461.
Hughes, CP, Gado, M
CT and aging of the brain. Radiology
1981; 139: 391–396.
LeMay, M, Stafford, JL, Sandor, T
et al. Statistical assessment of perceptual CT scan ratings in patients with Alzheimer type dementia. J Comput Assist Tomogr
1986; 10(5): 802–809.
Golomb, J, de Leon, MJ, Kluger, A
et al. Hippocampal atrophy in normal aging. An association with recent memory impairment. Arch Neurol
1993; 509: 967–973.
Itoh, M, Hatazawa, J, Miyazawa, H
et al. Stability of cerebral blood flow and oxygen metabolism during normal aging. Gerontology
1990; 36(1): 43–48.
DeCarli, C, Kaye, JA, Horwitz, B, Rapoport, SI
Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology
1990; 40: 872–883.
Willmer, J, Carruthers, A, Guzman, DA
et al. The usefulness of CT scanning in diagnosing dementia of the Alzheimer type. Can J Neurol Sci
1993; 20: 210–216.
de Leon, MJ, Ferris, SH, George, AE
et al. Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer’s disease. J Cereb Blood Flow Metab
1983; 3(3): 391–394.
Soininen, H, Reinikainen, KJ, Puranen, M, et al. Wide third ventricle correlates with low choline acetyltransferase activity of the neocortex in Alzheimer patients. Alzheimer Dis Assoc Disord
1993; 7(1): 39–47.
Convit, A, de Leon, MJ, Golomb, J
et al. Hippocampal atrophy in early Alzheimer’s disease: anatomic specificity and validation. Psychiatr Q
1993; 64(4): 371–387.
Tanna, NK, Kohn, MI, Horwich, DN
et al. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. Radiology
1991; 178(1): 123–130.
Matsuzawa, T, Hishinuma, T, Matsui, H
et al. Severe atrophy of amygdala and hippocampus in both Alzheimer’s disease and multi-infarct dementia. Sci Rep Res Inst Tohoku Univ
1990; 37(1–4): 23–25.
de Leon, MJ, Golomb, J, George, AE
et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. Am J Neurolradiol
1993; 14(4): 897–906.
Jobst, KA, Smith, AD, Szatmari, M
et al. Detection in life of confirmed Alzheimer’s disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet
1992; 340(8829): 1179–1183.
George, AE, de Leon, MJ, Stylopoulos, LA
et al. CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. Am J Neuroradiol
1990; 11: 101–107.
Kido, DK, Caine, ED, LeMay, M
et al. Temporal lobe atrophy in patients with Alzheimer disease: a CT study. Am J Neuroradiol
1989; 10: 551–555.
Jobst, KA, Hindley, NJ, King, E, Smith, AD
The Diagnosis of Alzheimer’s Disease: a Question of Image?
J Clin Psychiatry
1994; 55(Suppl 11): 22–31.
McKhann, G, Drachman, DA, Folstein, M
et al. Clinical diagnosis of Alzheimer’s disease — Report of the the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology
1984; 34: 939–944.
American Psychiatric Association : Diagnostic and statistical manual of mental disorders (DSM III-R)
, ed 3, Washington DC, American Psychiatric Association, 1987.
Crockett, D, Tuokko, H, Koch, W, Parks, R
The assessment of everyday functioning using the Present Functioning Questionnaire and the Functional Rating Scale in elderly samples. Clin Gerontol
1989; 8: 3–25.
Feldman, H, Schulzer, M, Wang, S, Tuokko, H, Beattie, BL
The Functional Rating Scale in Alzheimer’s disease assessment: a longitudinal study. In: Iqbal, K, Mortimer, JA, Winblad, B, Wisniewski, HM, eds. Research Advances in Alzheimer’s Disease and Related Disorders. London: John Wiley & Sons, 1995: 235–241.
Crook, TH, Larrabee, GJ, Youngjohn, JR
Diagnosis and assessment of age-associated memory impairment. [Review]. Clin Neuropharm
1990; 13(Suppl 3): S81–S91.
Ebly, EM, Hogan, DB, Parhad, IM
Cognitive Impairment in the nondemented elderly: results from the Canadian Study of Health and Aging. Arch Neurol
1995; 52: 612–619.
Hurwitz, TA, Ammann, W, Chu, D
et al. Single photon emission computed tomography using 99m Tc-HM-PAO in the routine evaluation of Alzheimer’s disease. Can J Neurol Sci
1991; 18: 59–62.
Gomori, JM, Steiner, I, Melamed, E, Cooper, G
The assessment of changes in brain volume using combined linear measurements. A CT-scan study. Neuroradiology
1984; 26: 21–24.
Brinkman, SD, Sarwar, M, Levin, HS, Morris, HH
Quantitative indexes of computed tomography in dementia and normal aging. Radiology
1981; 138: 89–92.
Soininen, H, Puranen, M, Riekkinen, PJ
Computed tomography findings in senile dementia and normal aging. J Neurol Neurosurg Psychiatry
1995; 45: 50–54.
Van den Bossche, B, Maes, M, Brussaard, C
et al. Computed tomography of the brain in unipolar depression. J Affective Disord
1991; 21(1): 67–74.
Aylward, EH, Karagiozis, H, Pearlson, G, Folstein, MF
Suprasellar cistern measures as a reflection of dementia in Alzheimer’s disease but not Huntington’s disease. J Psychiatr Res
1991; 25(1–2): 31–47.
Hirashima, Y, Shindo, K, Endo, S
Measurement of the area of the anterior horn of the right lateral ventricle for the diagnosis of brain atrophy by CT. Neuroradiology
1983; 25: 23–27.
Tests for comparing elements of a correlation matrix. Psychol Bull
1980; 87(2): 245–251.
Morris, JC, McKeel, DW, Fulling, K, Torack, RM, Berg, L
Validation of Clinical Diagnostic Criteria for Alzheimer’s Disease. Ann Neurol
1988; 24: 17–22.
Tierney, MC, Fisher, RH, Lewis, AJ
et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology
1988; 38: 359–364.
Blacker, D, Albert, MS, Bassett, SS
et al. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer’s disease. Arch Neurol
1994; 51: 1198–1204.
Holman, BL, Johnson, KA, Gerada, B, Carvalho, PA, Satlin, A
The scintigraphic appearance of Alzheimer’s disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med
1992; 33: 181–185.
Jagust, WJ, Johnson, KA, Holman, BL
SPECT Perfusion Imaging in the Diagnosis of Dementia. J Neuroimaging
1995; 5(Suppl 1): s45–s52.
Johnson, KA, Kijewski, MF, Becker, JA
et al. Quantitative brain SPECT in Alzheimer’s disease and normal aging. J Nucl Med
1993; 34(11): 2044–2048.
Tuokko, H, Vernon-Wilkinson, RV, Weir, J, Beattie, BL
Cued recall and the early identification of dementia. J Clin Exp Neuropsychol
1991; 13: 871–879.
Petersen, RC, Smith, GE, Ivnik, RJ, Kokmen, E, Tangalos, EG
Memory function in very early Alzheimer’s disease. Neurology
1994; 44: 867–872.
Chawluk, JB, Dann, R, Alavi, A
et al. The effect of focal cerebral atrophy in positron emission tomographic studies of aging and dementia. Nucl Med Biol
1990; 17: 797–804.
Eberling, JL, Jagust, WJ, Reed, BR, Baker, MG
Reduced temporal lobe blood flow in Alzheimer’s disease. Neurobiol Aging
1992; 13: 483–491.
Brun, A, Englund, E
Regional pattern of degeneration in Alzheimer’s disease: neuronal loss and histopathological grading. Histopathology
1981; 5: 549–564.
Friedland, RP, Brun, A, Budinger, TF
Pathological and positron emission tomographic correlations in Alzheimer’s disease. Lancet
1985; 1: 228.